210 related articles for article (PubMed ID: 23794399)
1. VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.
Slattery ML; Lundgreen A; Wolff RK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E140-50. PubMed ID: 23794399
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.
Slattery ML; John EM; Torres-Mejia G; Lundgreen A; Lewinger JP; Stern MC; Hines L; Baumgartner KB; Giuliano AR; Wolff RK
Int J Cancer; 2014 Feb; 134(3):629-44. PubMed ID: 23832257
[TBL] [Abstract][Full Text] [Related]
3. Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans.
Jang MJ; Jeon YJ; Kim JW; Cho YK; Lee SK; Hwang SG; Oh D; Kim NK
Mol Carcinog; 2013 Nov; 52 Suppl 1():E60-9. PubMed ID: 23169005
[TBL] [Abstract][Full Text] [Related]
4. Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.
Eng L; Azad AK; Qiu X; Kong QQ; Cheng D; Ying N; Tse A; Kuang Q; Dodbiba L; Renouf DJ; Marsh S; Savas S; Mackay HJ; Knox JJ; Darling GE; Wong RK; Xu W; Liu G; Faluyi OO
Carcinogenesis; 2015 Sep; 36(9):956-62. PubMed ID: 26014353
[TBL] [Abstract][Full Text] [Related]
5. Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCγ-cPLA(2) activation and retinal neovascularization.
Singh NK; Hansen DE; Kundumani-Sridharan V; Rao GN
Blood; 2013 Mar; 121(10):1911-23. PubMed ID: 23319572
[TBL] [Abstract][Full Text] [Related]
6. Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer.
Sohn BS; Park SJ; Kim JE; Kim KP; Hong YS; Suh C; Kim YS; Kim SY; Im SA; Kim SY; Kim JH; Ahn JB; Park YS; Kim TW
Oncology; 2014; 87(5):280-92. PubMed ID: 25139485
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.
Försti A; Jin Q; Altieri A; Johansson R; Wagner K; Enquist K; Grzybowska E; Pamula J; Pekala W; Hallmans G; Lenner P; Hemminki K
Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673
[TBL] [Abstract][Full Text] [Related]
8. A pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer.
Slattery ML; Wolff RK; Lundgreen A
Carcinogenesis; 2015 Jan; 36(1):49-59. PubMed ID: 25330801
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis.
Machado MV; Janeiro A; Miltenberger-Miltenyi G; Cortez-Pinto H
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):438-43. PubMed ID: 24445728
[TBL] [Abstract][Full Text] [Related]
10. FMS-like tyrosine kinase 1 (FLT1) is a key regulator of fetoplacental endothelial cell migration and angiogenesis.
Ji S; Xin H; Li Y; Su EJ
Placenta; 2018 Oct; 70():7-14. PubMed ID: 30316329
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
Slattery ML; Herrick JS; Lundgreen A; Fitzpatrick FA; Curtin K; Wolff RK
Carcinogenesis; 2010 Sep; 31(9):1604-11. PubMed ID: 20622004
[TBL] [Abstract][Full Text] [Related]
12. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Chlouverakis G; Vourvouhaki E; Turley H; Harris AL; Gatter KC
Eur J Clin Invest; 2007 Nov; 37(11):878-86. PubMed ID: 17883421
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphisms/haplotypes of the genes encoding vascular endothelial growth factor and its KDR receptor with recurrent pregnancy loss.
Su MT; Lin SH; Lee IW; Chen YC; Kuo PL
Hum Reprod; 2011 Apr; 26(4):758-64. PubMed ID: 21257617
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.
Beeghly-Fadiel A; Shu XO; Lu W; Long J; Cai Q; Xiang YB; Zheng Y; Zhao Z; Gu K; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):33-41. PubMed ID: 21119072
[TBL] [Abstract][Full Text] [Related]
16. Associations of
Vasconcelos VCA; Lourenço GJ; Brito ABC; Vasconcelos VL; Maldaun MVC; Tedeschi H; Marie SKN; Shinjo SMO; Lima CSP
Tumour Biol; 2019 Sep; 41(9):1010428319872092. PubMed ID: 31486713
[TBL] [Abstract][Full Text] [Related]
17. [Expression of vascular endothelial growth factor and its receptors KDR and Flt1 in acute myeloid leukemia].
Wang Y; Xiao ZJ; Liu P; Yang C; Yang RC; Cai YL; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):249-52. PubMed ID: 12859876
[TBL] [Abstract][Full Text] [Related]
18. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease.
Li L; Pan Y; Dai L; Liu B; Zhang D
Med Sci Monit; 2016 Jan; 22():31-40. PubMed ID: 26726843
[TBL] [Abstract][Full Text] [Related]
19. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer.
Hansen TF; Jakobsen A
Pharmacogenomics; 2011 Dec; 12(12):1681-93. PubMed ID: 22118052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
